Marino Stram & Associates LLC Lowers Position in The Procter & Gamble Company (NYSE:PG)

Marino Stram & Associates LLC lessened its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 1.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 19,350 shares of the company’s stock after selling 248 shares during the period. Procter & Gamble makes up about 0.8% of Marino Stram & Associates LLC’s investment portfolio, making the stock its 22nd largest position. Marino Stram & Associates LLC’s holdings in Procter & Gamble were worth $3,191,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of PG. Advantage Trust Co bought a new position in Procter & Gamble during the fourth quarter valued at $28,000. Naples Money Management LLC purchased a new stake in shares of Procter & Gamble during the fourth quarter valued at $29,000. Ruedi Wealth Management Inc. boosted its stake in shares of Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after purchasing an additional 77 shares during the period. Transcendent Capital Group LLC purchased a new stake in shares of Procter & Gamble during the fourth quarter valued at $31,000. Finally, MeadowBrook Investment Advisors LLC purchased a new stake in shares of Procter & Gamble during the fourth quarter valued at $33,000. Institutional investors own 65.77% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on PG shares. TD Cowen started coverage on shares of Procter & Gamble in a research note on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price objective for the company. Argus raised their price target on shares of Procter & Gamble from $180.00 to $185.00 and gave the company a “buy” rating in a report on Thursday, April 25th. Barclays lowered their price target on shares of Procter & Gamble from $174.00 to $163.00 and set an “overweight” rating on the stock in a report on Thursday, August 1st. Citigroup raised their price target on shares of Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Finally, Jefferies Financial Group cut shares of Procter & Gamble from a “buy” rating to a “hold” rating and lowered their price target for the company from $182.00 to $175.00 in a report on Wednesday, July 24th. Nine research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $173.95.

View Our Latest Stock Report on Procter & Gamble

Insider Activity

In other news, CEO Sundar G. Raman sold 31,924 shares of the business’s stock in a transaction dated Monday, May 20th. The shares were sold at an average price of $166.95, for a total transaction of $5,329,711.80. Following the transaction, the chief executive officer now owns 19,042 shares of the company’s stock, valued at approximately $3,179,061.90. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, CEO R. Alexandra Keith sold 3,373 shares of the business’s stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $170.00, for a total value of $573,410.00. Following the sale, the chief executive officer now directly owns 21,513 shares in the company, valued at approximately $3,657,210. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Sundar G. Raman sold 31,924 shares of the business’s stock in a transaction dated Monday, May 20th. The stock was sold at an average price of $166.95, for a total transaction of $5,329,711.80. Following the sale, the chief executive officer now owns 19,042 shares in the company, valued at $3,179,061.90. The disclosure for this sale can be found here. In the last quarter, insiders have sold 116,313 shares of company stock valued at $19,703,643. 0.17% of the stock is currently owned by insiders.

Procter & Gamble Price Performance

Procter & Gamble stock traded down $0.03 during trading on Friday, reaching $167.89. The company had a trading volume of 5,640,925 shares, compared to its average volume of 6,674,588. The firm’s 50-day simple moving average is $166.99 and its 200 day simple moving average is $163.22. The Procter & Gamble Company has a 1-year low of $141.45 and a 1-year high of $171.72. The firm has a market capitalization of $396.24 billion, a PE ratio of 27.43, a price-to-earnings-growth ratio of 3.70 and a beta of 0.41. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The company had revenue of $20.53 billion for the quarter, compared to analysts’ expectations of $20.69 billion. During the same quarter in the previous year, the company posted $1.37 EPS. The firm’s quarterly revenue was down .1% on a year-over-year basis. As a group, equities research analysts anticipate that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were given a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, July 19th. This represents a $4.03 annualized dividend and a dividend yield of 2.40%. Procter & Gamble’s payout ratio is 65.69%.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.